A Commonwealth Court judge who presided over trials in Pennsylvania’s suits against pharmaceutical companies for overcharging the state for prescription drug reimbursements has denied post-trial motions from both the state and two drug companies.

In ruling on the motions, Judge Robert E. Simpson Jr. denied the state’s appeals in Commonwealth v. TAP Pharmaceutical Products regarding jury and bench verdicts issued separately against Bristol-Myers Squibb and Johnson & Johnson. He also denied the post-trial motions raised by the two pharmaceutical companies.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Advance® Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]